 | • レポートコード：QYR9ST07559 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、デュシェンヌ型筋ジストロフィーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、デフラザコート、プレドニゾン、その他に、用途別には、男性用、女性用にセグメント区分し、デュシェンヌ型筋ジストロフィーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・デュシェンヌ型筋ジストロフィーの世界市場概要 ・デュシェンヌ型筋ジストロフィーの製造コスト構成分析 ・デュシェンヌ型筋ジストロフィーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・デュシェンヌ型筋ジストロフィーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・デュシェンヌ型筋ジストロフィーのセグメント分析（種類別） （デフラザコート、プレドニゾン、その他） ・デュシェンヌ型筋ジストロフィーのセグメント分析（用途別） （男性用、女性用） ・デュシェンヌ型筋ジストロフィーの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （PTC Therapeutics、Sarepta Therapeutics、Others） ・デュシェンヌ型筋ジストロフィーの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys’ respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.The classification of duchenne muscular dystrophy includes deflazacort, prednisone and others. And the proportion of deflazacort in 2017 is about 44%.
Duchenne muscular dystrophy is widely used by Male patients and Female patients. The most proportion of duchenne muscular dystrophy sold to Male patients, and the proportion in 2017 is about 81%.
The global Duchenne Muscular Dystrophy market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Duchenne Muscular Dystrophy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Duchenne Muscular Dystrophy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Duchenne Muscular Dystrophy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Duchenne Muscular Dystrophy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
PTC Therapeutics
Sarepta Therapeutics
Others
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Deflazacort
Prednisone
Others
Segment by Application
Male
Female
Table of Contents
Executive Summary
1 Industry Overview of Duchenne Muscular Dystrophy
1.1 Definition of Duchenne Muscular Dystrophy
1.2 Duchenne Muscular Dystrophy Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Deflazacort
1.2.3 Prednisone
1.2.4 Others
1.3 Duchenne Muscular Dystrophy Segment by Applications
1.3.1 Global Duchenne Muscular Dystrophy Consumption Comparison by Applications (2014-2025)
1.3.2 Male
1.3.3 Female
1.4 Global Duchenne Muscular Dystrophy Overall Market
1.4.1 Global Duchenne Muscular Dystrophy Revenue (2014-2025)
1.4.2 Global Duchenne Muscular Dystrophy Production (2014-2025)
1.4.3 North America Duchenne Muscular Dystrophy Status and Prospect (2014-2025)
1.4.4 Europe Duchenne Muscular Dystrophy Status and Prospect (2014-2025)
1.4.5 China Duchenne Muscular Dystrophy Status and Prospect (2014-2025)
1.4.6 Japan Duchenne Muscular Dystrophy Status and Prospect (2014-2025)
1.4.7 Southeast Asia Duchenne Muscular Dystrophy Status and Prospect (2014-2025)
1.4.8 India Duchenne Muscular Dystrophy Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Duchenne Muscular Dystrophy
2.3 Manufacturing Process Analysis of Duchenne Muscular Dystrophy
2.4 Industry Chain Structure of Duchenne Muscular Dystrophy
3 Development and Manufacturing Plants Analysis of Duchenne Muscular Dystrophy
3.1 Capacity and Commercial Production Date
3.2 Global Duchenne Muscular Dystrophy Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Duchenne Muscular Dystrophy
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Duchenne Muscular Dystrophy Production and Capacity Analysis
4.2 Duchenne Muscular Dystrophy Revenue Analysis
4.3 Duchenne Muscular Dystrophy Price Analysis
4.4 Market Concentration Degree
5 Duchenne Muscular Dystrophy Regional Market Analysis
5.1 Duchenne Muscular Dystrophy Production by Regions
5.1.1 Global Duchenne Muscular Dystrophy Production by Regions
5.1.2 Global Duchenne Muscular Dystrophy Revenue by Regions
5.2 Duchenne Muscular Dystrophy Consumption by Regions
5.3 North America Duchenne Muscular Dystrophy Market Analysis
5.3.1 North America Duchenne Muscular Dystrophy Production
5.3.2 North America Duchenne Muscular Dystrophy Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Duchenne Muscular Dystrophy Import and Export
5.4 Europe Duchenne Muscular Dystrophy Market Analysis
5.4.1 Europe Duchenne Muscular Dystrophy Production
5.4.2 Europe Duchenne Muscular Dystrophy Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Duchenne Muscular Dystrophy Import and Export
5.5 China Duchenne Muscular Dystrophy Market Analysis
5.5.1 China Duchenne Muscular Dystrophy Production
5.5.2 China Duchenne Muscular Dystrophy Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Duchenne Muscular Dystrophy Import and Export
5.6 Japan Duchenne Muscular Dystrophy Market Analysis
5.6.1 Japan Duchenne Muscular Dystrophy Production
5.6.2 Japan Duchenne Muscular Dystrophy Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Duchenne Muscular Dystrophy Import and Export
5.7 Southeast Asia Duchenne Muscular Dystrophy Market Analysis
5.7.1 Southeast Asia Duchenne Muscular Dystrophy Production
5.7.2 Southeast Asia Duchenne Muscular Dystrophy Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Duchenne Muscular Dystrophy Import and Export
5.8 India Duchenne Muscular Dystrophy Market Analysis
5.8.1 India Duchenne Muscular Dystrophy Production
5.8.2 India Duchenne Muscular Dystrophy Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Duchenne Muscular Dystrophy Import and Export
6 Duchenne Muscular Dystrophy Segment Market Analysis (by Type)
6.1 Global Duchenne Muscular Dystrophy Production by Type
6.2 Global Duchenne Muscular Dystrophy Revenue by Type
6.3 Duchenne Muscular Dystrophy Price by Type
7 Duchenne Muscular Dystrophy Segment Market Analysis (by Application)
7.1 Global Duchenne Muscular Dystrophy Consumption by Application
7.2 Global Duchenne Muscular Dystrophy Consumption Market Share by Application (2014-2019)
8 Duchenne Muscular Dystrophy Major Manufacturers Analysis
8.1 PTC Therapeutics
8.1.1 PTC Therapeutics Duchenne Muscular Dystrophy Production Sites and Area Served
8.1.2 PTC Therapeutics Product Introduction, Application and Specification
8.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sarepta Therapeutics
8.2.1 Sarepta Therapeutics Duchenne Muscular Dystrophy Production Sites and Area Served
8.2.2 Sarepta Therapeutics Product Introduction, Application and Specification
8.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Others
8.3.1 Others Duchenne Muscular Dystrophy Production Sites and Area Served
8.3.2 Others Product Introduction, Application and Specification
8.3.3 Others Duchenne Muscular Dystrophy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
9 Development Trend of Analysis of Duchenne Muscular Dystrophy Market
9.1 Global Duchenne Muscular Dystrophy Market Trend Analysis
9.1.1 Global Duchenne Muscular Dystrophy Market Size (Volume and Value) Forecast 2019-2025
9.2 Duchenne Muscular Dystrophy Regional Market Trend
9.2.1 North America Duchenne Muscular Dystrophy Forecast 2019-2025
9.2.2 Europe Duchenne Muscular Dystrophy Forecast 2019-2025
9.2.3 China Duchenne Muscular Dystrophy Forecast 2019-2025
9.2.4 Japan Duchenne Muscular Dystrophy Forecast 2019-2025
9.2.5 Southeast Asia Duchenne Muscular Dystrophy Forecast 2019-2025
9.2.6 India Duchenne Muscular Dystrophy Forecast 2019-2025
9.3 Duchenne Muscular Dystrophy Market Trend (Product Type)
9.4 Duchenne Muscular Dystrophy Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Duchenne Muscular Dystrophy Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Duchenne Muscular Dystrophy Production Market Share by Types in 2018
Figure Deflazacort Product Picture
Figure Prednisone Product Picture
Figure Others Product Picture
Table Global Duchenne Muscular Dystrophy Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Duchenne Muscular Dystrophy Consumption Market Share by Applications in 2018
Figure Male
Figure Female
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) (2014-2025)
Figure Global Duchenne Muscular Dystrophy Production (K Doses) (2014-2025)
Figure North America Duchenne Muscular Dystrophy Market Size (Million USD) (2014-2025)
Figure Europe Duchenne Muscular Dystrophy Market Size (Million USD) (2014-2025)
Figure China Duchenne Muscular Dystrophy Market Size (Million USD) (2014-2025)
Figure Japan Duchenne Muscular Dystrophy Market Size (Million USD) (2014-2025)
Figure Southeast Asia Duchenne Muscular Dystrophy Market Size (Million USD) (2014-2025)
Figure India Duchenne Muscular Dystrophy Market Size (Million USD) (2014-2025)
Table Duchenne Muscular Dystrophy Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Duchenne Muscular Dystrophy in 2018
Figure Manufacturing Process Analysis of Duchenne Muscular Dystrophy
Figure Industry Chain Structure of Duchenne Muscular Dystrophy
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Duchenne Muscular Dystrophy Manufacturing Plants Distribution
Table Duchenne Muscular Dystrophy Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Duchenne Muscular Dystrophy Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Duchenne Muscular Dystrophy Production (K Doses) of Major Manufacturers (2014-2019)
Table Duchenne Muscular Dystrophy Production Market Share of Major Manufacturers (2014-2019)
Figure Duchenne Muscular Dystrophy Production Share by Manufacturers in 2018
Table Duchenne Muscular Dystrophy Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Duchenne Muscular Dystrophy Revenue Market Share of Major Manufacturers (2014-2019)
Figure Duchenne Muscular Dystrophy Revenue Share by Manufacturers in 2018
Table Duchenne Muscular Dystrophy Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Duchenne Muscular Dystrophy Production by Regions 2014-2019 (K Doses)
Table Global Duchenne Muscular Dystrophy Production Market Share by Regions 2014-2019
Figure Global Duchenne Muscular Dystrophy Production Market Share by Regions in 2018
Table Global Duchenne Muscular Dystrophy Revenue by Regions 2014-2019 (Million USD)
Table Global Duchenne Muscular Dystrophy Revenue Market Share by Regions 2014-2019
Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Regions in 2018
Table Global Duchenne Muscular Dystrophy Consumption by Regions 2014-2019 (K Doses)
Table Global Duchenne Muscular Dystrophy Consumption Market Share by Regions 2014-2019
Figure North America Duchenne Muscular Dystrophy Production Growth Rate 2014-2019 (K Doses)
Figure North America Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million USD)
Table North America Duchenne Muscular Dystrophy Production, Consumption Import and Export (K Doses)
Figure Europe Duchenne Muscular Dystrophy Production Growth Rate 2014-2019 (K Doses)
Figure Europe Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Duchenne Muscular Dystrophy Production, Consumption Import and Export (K Doses)
Figure China Duchenne Muscular Dystrophy Production Growth Rate 2014-2019 (K Doses)
Figure China Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million USD)
Table China Duchenne Muscular Dystrophy Production, Consumption Import and Export (K Doses)
Figure Japan Duchenne Muscular Dystrophy Production Growth Rate 2014-2019 (K Doses)
Figure Japan Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Duchenne Muscular Dystrophy Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Duchenne Muscular Dystrophy Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Duchenne Muscular Dystrophy Production, Consumption Import and Export (K Doses)
Figure India Duchenne Muscular Dystrophy Production Growth Rate 2014-2019 (K Doses)
Figure India Duchenne Muscular Dystrophy Revenue Growth Rate 2014-2019 (Million USD)
Table India Duchenne Muscular Dystrophy Production, Consumption Import and Export (K Doses)
Figure Global Consumption Duchenne Muscular Dystrophy Market Share by Application (2014-2019)
Figure Global Value (Consumption) Duchenne Muscular Dystrophy Market Share by Application (2014-2019)
Table PTC Therapeutics Duchenne Muscular Dystrophy Production Sites and Area Served
Table PTC Therapeutics Duchenne Muscular Dystrophy Product Introduction, Application and Specification
Table PTC Therapeutics Duchenne Muscular Dystrophy Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table PTC Therapeutics Duchenne Muscular Dystrophy Production Growth Rate (2014-2019)
Table PTC Therapeutics Duchenne Muscular Dystrophy Production Market Share (2014-2019)
Figure PTC Therapeutics Duchenne Muscular Dystrophy Revenue Market Share (2014-2019)
Table PTC Therapeutics Duchenne Muscular Dystrophy Main Business and Markets Served
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Production Sites and Area Served
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Product Introduction, Application and Specification
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Production Growth Rate (2014-2019)
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Production Market Share (2014-2019)
Figure Sarepta Therapeutics Duchenne Muscular Dystrophy Revenue Market Share (2014-2019)
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Main Business and Markets Served
Table Others Duchenne Muscular Dystrophy Production Sites and Area Served
Table Others Duchenne Muscular Dystrophy Product Introduction, Application and Specification
Table Others Duchenne Muscular Dystrophy Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Others Duchenne Muscular Dystrophy Production Growth Rate (2014-2019)
Table Others Duchenne Muscular Dystrophy Production Market Share (2014-2019)
Figure Others Duchenne Muscular Dystrophy Revenue Market Share (2014-2019)
Table Others Duchenne Muscular Dystrophy Main Business and Markets Served
Figure Global Duchenne Muscular Dystrophy Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Duchenne Muscular Dystrophy Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Duchenne Muscular Dystrophy Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Duchenne Muscular Dystrophy Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Duchenne Muscular Dystrophy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Duchenne Muscular Dystrophy Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Duchenne Muscular Dystrophy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Duchenne Muscular Dystrophy Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Duchenne Muscular Dystrophy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Duchenne Muscular Dystrophy Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Duchenne Muscular Dystrophy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Duchenne Muscular Dystrophy Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Duchenne Muscular Dystrophy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Duchenne Muscular Dystrophy Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Duchenne Muscular Dystrophy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Duchenne Muscular Dystrophy by Type (2019-2025)
Table Global Consumption (K Doses) of Duchenne Muscular Dystrophy by Application (2019-2025)
Table Duchenne Muscular Dystrophy Distributors List
Table Duchenne Muscular Dystrophy Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
デュシェンヌ型筋ジストロフィー治療薬の世界市場：市場規模・現状・予測 Duchenne muscular dystrophy (DMD) therapeutics helps treat genetic disorder caused due to absence of dystrophin, a protein in the body. The symptoms of the disease include weakness in the muscles of the hips, pelvic area, thighs, and shoulders, and later in the muscles of arms, legs, and trunk.Facto…- デュシェンヌ型筋ジストロフィー治療薬の世界市場：市場規模・現状・予測 Duchenne muscular dystrophy (DMD) therapeutics helps treat genetic disorder caused due to absence of dystrophin, a protein in the body. The symptoms of the disease include weakness in the muscles of the hips, pelvic area, thighs, and shoulders, and later in the muscles of arms, legs, and trunk.Facto…
- 世界の子供解剖学的モデル市場：動向・競争分析 Child anatomical models are kinds of children models to study and explain both the internal and external structure of the human body or animals as well as the various functions of the body's systems.The Child Anatomical Models market was valued at xx Million US$ in 2018 and is projected to reach xx …
- 世界の医薬品グレード人造樟脳市場：専門的調査 Camphor is conventionally prepared from the extracts of the camphor tree, while the one produced using chemical synthesis is known as synthetic camphor. One of the most important raw material employed in the manufacturing of synthetic camphor is turpentine oil. Pharmaceutical grade synthetic camphor…
- 女性用滅菌装置の世界市場：市場規模・現状・予測 Female sterilization is one of the modern contraceptive methods widely preferred around the globe followed by contraceptive pills, IUDs, and condoms.It is a permanent method of contraception and has helped in monitoring of population growth especially in developing countries. In 2018, the global Fem…